These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23223006)

  • 1. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
    Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
    J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.
    Tolami HF; Sharafshah A; Tolami LF; Keshavarz P
    J Mol Neurosci; 2020 Apr; 70(4):504-513. PubMed ID: 31853823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B; Moula O; Ghachem R
    Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone Dosage and Plasma Levels, SNPs of OPRM1 Gene and Age of First Drug Use Were Associated With Outcomes of Methadone Maintenance Treatment.
    Peng S; Jiang H; Du J; Lin S; Pan S; Yu S; Zhao M
    Front Genet; 2018; 9():450. PubMed ID: 30420869
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
    Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
    J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
    Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
    Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
    Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
    Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
    AlMeman AA; Ismail R; Perola M
    Drug Metab Lett; 2016; 10(3):213-218. PubMed ID: 27515451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.
    Bunten H; Liang WJ; Pounder DJ; Seneviratne C; Osselton D
    Clin Pharmacol Ther; 2010 Sep; 88(3):383-9. PubMed ID: 20668445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.
    Wang SC; Ho IK; Tsou HH; Tian JN; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Chen CY; Liu SC; Wu HY; Chan HW; Tsai MH; Lin PS; Liu YL
    J Clin Psychopharmacol; 2011 Aug; 31(4):463-9. PubMed ID: 21694616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPRM1 gene is associated with BMI in Uyghur population.
    Xu L; Zhang F; Zhang DD; Chen XD; Lu M; Lin RY; Wen H; Jin L; Wang XF
    Obesity (Silver Spring); 2009 Jan; 17(1):121-5. PubMed ID: 19008867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
    Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
    Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
    J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.
    Yang HC; Chu SK; Huang CL; Kuo HW; Wang SC; Liu SW; Ho IK; Liu YL
    PLoS Genet; 2016 Mar; 12(3):e1005910. PubMed ID: 27010727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
    Liu CC; Fang CP; Liu TH; Kuo HW; Liu SC; Wang SC; Chen ACH; Liu YL
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():92-98. PubMed ID: 29330135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
    Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
    J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.